Evaluation of immunoglobulins, proinflammatory cytokines and lipid concentrations in patients with diabetic nephropathy treated with continual ambulatory peritoneal dialysis (CAPD).
Donica
H
H
Katedra i Zakład Biochemii Klinicznej Akademii Medycznej w Lublinie.
Kozioł-Montewka
M
M
Ksiazek
A
A
Starosławska
E
E
D018946:Chemokine CCL5 / Q000378:metabolism; D002784:Cholesterol / Q000097:blood; D008076:Cholesterol, HDL / Q000097:blood; D008078:Cholesterol, LDL / Q000097:blood; D016207:Cytokines / Q000378:metabolism*; D003924:Diabetes Mellitus, Type 2 / Q000378:metabolism*; D003928:Diabetic Nephropathies / Q000378:metabolism* / Q000628:therapy*; D006801:Humans; D007070:Immunoglobulin A / Q000378:metabolism; D007074:Immunoglobulin G / Q000378:metabolism; D007075:Immunoglobulin M / Q000378:metabolism; D007375:Interleukin-1 / Q000378:metabolism; D008055:Lipids / Q000097:blood*; D018384:Oxidative Stress; D010531:Peritoneal Dialysis, Continuous Ambulatory; D014280:Triglycerides / Q000097:blood; D014409:Tumor Necrosis Factor-alpha / Q000378:metabolism
D018946:Chemokine CCL5; D008076:Cholesterol, HDL; D008078:Cholesterol, LDL; D016207:Cytokines; D007070:Immunoglobulin A; D007074:Immunoglobulin G; D007075:Immunoglobulin M; D007375:Interleukin-1; D008055:Lipids; D014280:Triglycerides; D014409:Tumor Necrosis Factor-alpha; D002784:Cholesterol